AbbVie, Inc. (ABBV)
264.49
-0.47
(-0.18%)
USD |
NYSE |
Aug 24, 16:00
264.58
+0.09
(+0.03%)
After-Hours: 20:00
AbbVie Total Liabilities (Quarterly) : 141.00B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 141.00B |
| March 31, 2026 | 143.08B |
| December 31, 2025 | 137.19B |
| September 30, 2025 | 136.50B |
| June 30, 2025 | 137.32B |
| March 31, 2025 | 134.70B |
| December 31, 2024 | 131.80B |
| September 30, 2024 | 137.35B |
| June 30, 2024 | 135.12B |
| March 31, 2024 | 140.83B |
| December 31, 2023 | 124.31B |
| September 30, 2023 | 124.09B |
| June 30, 2023 | 122.47B |
| March 31, 2023 | 121.24B |
| December 31, 2022 | 121.52B |
| September 30, 2022 | 125.30B |
| June 30, 2022 | 128.50B |
| March 31, 2022 | 126.90B |
| December 31, 2021 | 131.09B |
| September 30, 2021 | 135.28B |
| June 30, 2021 | 135.38B |
| March 31, 2021 | 136.77B |
| December 31, 2020 | 137.47B |
| September 30, 2020 | 134.33B |
| June 30, 2020 | 134.80B |
| Date | Value |
|---|---|
| March 31, 2020 | 98.61B |
| December 31, 2019 | 97.29B |
| September 30, 2019 | 67.67B |
| June 30, 2019 | 65.71B |
| March 31, 2019 | 64.60B |
| December 31, 2018 | 67.80B |
| September 30, 2018 | 69.08B |
| June 30, 2018 | 65.02B |
| March 31, 2018 | 65.79B |
| December 31, 2017 | 65.69B |
| September 30, 2017 | 62.15B |
| June 30, 2017 | 60.98B |
| March 31, 2017 | 60.67B |
| December 31, 2016 | 61.46B |
| September 30, 2016 | 60.16B |
| June 30, 2016 | 61.57B |
| March 31, 2016 | 49.08B |
| December 31, 2015 | 49.10B |
| September 30, 2015 | 49.97B |
| June 30, 2015 | 48.35B |
| March 31, 2015 | 25.32B |
| December 31, 2014 | 25.80B |
| September 30, 2014 | 23.81B |
| June 30, 2014 | 23.83B |
| March 31, 2014 | 23.96B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 13.24B |
| Gilead Sciences, Inc. | 37.62B |
| Regeneron Pharmaceuticals, Inc. | 10.02B |
| Amgen, Inc. | 83.95B |
| REGENXBIO, Inc. | 314.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 135.12B |
| Shareholders Equity (Quarterly) | -5.935B |
| Debt to Equity Ratio | -11.93 |
| Current Ratio | 0.8085 |
| Net Debt Paydown Yield | -0.04% |